Company: MDCXW
Filing Date: 2025-09-29
Form Type: S-1
Source: 0001062993-25-015841
Chunk: 148

Company: Medicus Pharma Ltd.
Filing Date: 2025-09-29
Form: S-1
Chunk 148
---
ad Sciences for $550 million. Nexstar's primary drug, Ambisome, remains the standard of care today for the treatment of certain life-threatening fungal infections. Mr. Mahaffy began his career at Warburg Pincus, where he served as a venture capitalist from 1986 to 1992.

Mr. Mahaffy holds a Master's degree in International Affairs from Columbia University, which he completed in 1986, a year after obtaining his Bachelor's degree in International Affairs from Lewis and Clark College. Pat is also a long serving member of the Board of Trustees for Lewis & Clark College.

Carolyn Bonner, President and Acting Chief Financial Officer

Carolyn Bonner has served as our President since September 2023. On September 12, 2025, in connection with Mr. Quinlan's medical leave of absence, Ms. Bonner was appointed as acting Chief Financial Officer of the Company in addition to remaining the Company's President.

Ms. Bonner until recently was the President & CEO of Parkway Clinical Laboratories (2019 to 2023), a College of American pathologist (CAP), accredited diagnostic company, serving healthcare providers across the United States.

<div align='center'>108</div>

Ms. Bonner was the Director of Corporate Development at Building Beyond BRIC Investment Fund (2019 to 2023) where she was extensively involved in fundraising, marketing, and assisting with back office operations from May 2009 to December 2011.

Previously Ms. Bonner was the Director of Business Development at Parkway Clinical Laboratories ("PCL"), where she delivered client guided customization of PCL services and creative corporate partnerships. Carolyn also simultaneously served as Director of Corporate Development for Rosetta Genomics, a publicly traded Israeli biotech company, the parent company of PCL, from July 2008 to May 2009.

Ms. Bonner started her career in 2006 as a sales executive at Lakewood Pathology (now called PLUS Diagnostics), which is owned and operated by Water Street Healthcare Partners, a Chicago based private equity fund. Ms. Bonner has a B.A. focused in marketing from West Chester University.

James Quinlan, Chief Financial Officer

James Quinlan has served as our Chief Financial Officer since September 2023. On September 12, 2025, the Company announced that Mr. Quinlan will be taking a medical leave of absence commencing on such date.

Mr. Quinlan is a Certified Public Accountant, Certified Financial Planner